RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 114 filers reported holding RELMADA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $74,040,000 | +94.9% | 2,000,000 | 0.0% | 1.58% | +56.0% |
Q2 2022 | $37,980,000 | -29.6% | 2,000,000 | 0.0% | 1.01% | -14.0% |
Q1 2022 | $53,980,000 | +19.8% | 2,000,000 | 0.0% | 1.18% | +48.4% |
Q4 2021 | $45,060,000 | +53.3% | 2,000,000 | +156.0% | 0.79% | +47.6% |
Q3 2020 | $29,392,000 | -22.9% | 781,290 | -8.3% | 0.54% | -27.6% |
Q2 2020 | $38,123,000 | -19.0% | 851,907 | -38.3% | 0.74% | -50.0% |
Q1 2020 | $47,071,000 | +58.5% | 1,379,988 | +81.2% | 1.49% | +65.0% |
Q4 2019 | $29,705,000 | – | 761,666 | – | 0.90% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VR Adviser, LLC | 2,270,072 | $61,269,000 | 9.93% |
GREAT POINT PARTNERS LLC | 790,000 | $21,322,000 | 5.15% |
ACUTA CAPITAL PARTNERS, LLC | 342,000 | $9,231,000 | 4.31% |
COWEN AND COMPANY, LLC | 1,164,361 | $31,426,000 | 3.02% |
Altium Capital Management LP | 206,000 | $5,560,000 | 1.86% |
BVF INC/IL | 1,647,400 | $44,463,000 | 1.78% |
RTW INVESTMENTS, LP | 2,540,074 | $68,557,000 | 1.42% |
Vivo Capital, LLC | 705,882 | $19,052,000 | 1.31% |
RA Capital Management | 2,000,000 | $53,980,000 | 1.18% |
SPHERA FUNDS MANAGEMENT LTD. | 291,252 | $7,861,000 | 1.11% |